Travere Therapeutics TVTX
NASDAQ TVTX
$52.62 +0.04 (+0.08%)
As of: Oct 22, 2026 · 1:34 PM EDT

Travere Therapeutics (TVTX) Shares Repurchased (2014)

Updated

Analysis

Travere Therapeutics (TVTX) Shares Repurchased (2014) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Repurchased (Qtr)
1 Eli Lilly 1,170.58 Bn 1,139.17 Bn 19.71 Bn 1.60 Bn
2 Johnson & Johnson 645.51 Bn 565.37 Bn 17.30 Bn 1.71 Bn
3 AbbVie 502.28 Bn 475.39 Bn 12.70 Bn 9.00 Mn
4 Merck 363.81 Bn 318.18 Bn 12.21 Bn 757.00 Mn
5 Novartis Ag 302.62 Bn 266.61 Bn 11.24 Bn 1.20 Bn
6 Astrazeneca 268.13 Bn 241.81 Bn 12.86 Bn -
7 Amgen 242.20 Bn 197.60 Bn 7.24 Bn -
8 Gilead Sciences 193.87 Bn 168.07 Bn 6.22 Bn 355.00 Mn
9 Pfizer 172.06 Bn 118.71 Bn 10.94 Bn -
10 Travere Therapeutics 4.93 Bn 4.53 Bn 167.41 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2014 -336.00
Mar 31, 2014 2.26 Mn
API Access

Travere Therapeutics Shares Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-repurchased&ticker=TVTX&period=max&api_key=YOUR_API_KEY